Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,514 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Recruiting

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

NCT07527650

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations
  • Desert Clinical Research Mesa, Arizona, United States
  • Charter Research Orlando, Florida, United States
  • AdventHealth Translational Research Institute Orlando, Florida, United States
  • Centricity Research IRT - DBA IACT Health Columbus Piedmont Columbus, Georgia, United States
View all 15 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT07351058

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
Locations
  • Lakeview Clinical Research Guntersville, Alabama, United States
  • Arizona Clinical Trials Tucson, Arizona, United States
  • Orange County Research Center Lake Forest, California, United States
  • Ark Clinical Research Long Beach, California, United States
View all 193 locations
View Trial Details
Recruiting

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

NCT07743450

Conditions
Body Weight, Chronic Weight Management, Diabetes Mellitus, +12 more
Locations
  • AURORA-2 Clinical Site Birmingham, Alabama, United States
  • AURORA-2 Clinical Site Huntsville, Alabama, United States
  • AURORA-2 Clinical Site Peoria, Arizona, United States
  • AURORA-2 Clinical Site Phoenix, Arizona, United States
View all 136 locations
View Trial Details
Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

NCT07664553

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Ocoee, Florida, United States
  • Research Site Decatur, Georgia, United States
View all 132 locations
View Trial Details
Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

NCT07662044

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Daphne, Alabama, United States
  • Research Site Lomita, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site San Diego, California, United States
View all 150 locations
View Trial Details
Recruiting

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

NCT07662109

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Sheffield, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
View all 282 locations
View Trial Details
Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

NCT07662135

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations
  • Research Site Peoria, Arizona, United States
  • Research Site Surprise, Arizona, United States
  • Research Site Concord, California, United States
  • Research Site Sacramento, California, United States
View all 185 locations
View Trial Details
Recruiting

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

NCT07521475

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Sansum Diabetes Research Institute Santa Barbara, California, United States
  • Touro University California Vallejo, California, United States
  • University of Colorado Denver Denver, Colorado, United States
  • Metabolic Research Institute West Palm Beach, Florida, United States
View all 27 locations
View Trial Details
Recruiting

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

NCT07579702

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Sansum Diabetes Research Institute Santa Barbara, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Yale New Haven, Connecticut, United States
View Trial Details

Related conditions